恶化
医学
肺活量测定
慢性阻塞性肺病
指南
哮喘
相伴的
阻塞性肺病
重症监护医学
药物治疗
内科学
物理疗法
病理
作者
Wilson Quezada,Daniela Angulo,Susan Murray,Min J. Joo,MeiLan K. Han,Barry J. Make,Byron Thomashow,David M. Mannino,Hazel Tapp,Fernando J. Martínez,Barbara P. Yawn
标识
DOI:10.1016/j.rmed.2024.107695
摘要
Initial chronic obstructive lung disease (COPD) pharmacotherapy is based on symptom burden and exacerbation history. Inclusion of inhaled cortico-steroids (ICS) is recommended only for those with a history of exacerbations. This brief report highlights that among individuals with previously unrecognized COPD about 1 in 5 have one or more exacerbation-like events and about 1 in 10 have two or more events in the prior 12 months whether or not they self-report concomitant asthma. Closer attention to prior exacerbation-like event history might lead to more guideline concordant care. In addition, there are two other groups that have impaired but non-obstructive spirometry, some with significant respiratory symptom burden who have frequencies of exacerbation-like events similar to those meeting COPD spirometry criteria. To date we have little guidance for treatment of these individuals.
科研通智能强力驱动
Strongly Powered by AbleSci AI